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Abstract.  A novel microtubule-associated protein 
(MAP) of Mr 115,000 has been identified by screening 
of a HeLa cell eDNA expression library with an anti- 
serum raised against microtubule-binding proteins 
from HeLa cells. Monoclonal and afffinity-purified 
polyclonal antibodies were generated for the further 
characterization of this MAP. It is different from the 
microtubule-binding proteins of similar molecular 
weights, characterized so far, by its nucleotide- 
insensitive binding to microtubules and different 
sedimentation behavior. Since it is predominantly ex- 
pressed in cells of epithelial origin (Caco-2, HeLa, 
MDCK), and rare (human skin, A72) or not detect- 
able (Vero) in fibroblastic cells, we name it E-MAP- 
115  (epithelial MAP of 115 kD). In HeLa cells, 
E-MAP-115  is preferentially associated with subdo- 
mains or subsets of perinuclear microtubules. In 
Caco-2 cells, labeling for E-MAP-115  increases when 
they polarize and form blisters. 
The molecular characterization of E-MAP-115  re- 
veals that it is a novel protein with no significant ho- 
mologies to other known proteins. The secondary 
structure predicted from its sequence indicates two do- 
mains connected by a putative hinge region rich in 
proline and alanine (PAPA region). E-MAP-115  has 
two highly charged regions with predicted t~-helieal 
structure, one basic with a pI of 10.9 in the NH2- 
terminal domain and one neutral with a pI of 7.6 im- 
mediately following the PAPA region in the acidic 
COOH-terminal half of the molecule. A novel 
microtubule-binding site has been localized to the ba- 
sic or-helical region in the NH2-terminal domain using 
in vitro microtubule-binding assays and expression of 
mutant polypeptides in vivo. Overexpression of this 
domain of E-MAP-115  by transfection of fibroblasts 
lacking significant levels of this protein with its cDNA 
renders microtubules stable to nocodazole. We con- 
clude that E-MAP-115  is a microtubule-stabilizing pro- 
tein that may play an important role during reorgani- 
zation of microtubules during polarization and 
differentiation of epithelial cells. 
PITHELIAL cells  exhibit  a  structural and functional 
asymmetry referred to as apical-basal  polarity. The 
establishment of  this polarity has been studied in epi- 
thelial cell models such as MDCK and Caco-2, and microtu- 
bules have been implicated in this process (for reviews see 
Rodriguez-Boulan  and  Nelson,  1989; Simons  and  Wan- 
dinger-Ness,  1990). Microtubules are nucleated by pericen- 
triolar material in the perinuclear region of the microtubule- 
organizing center (MTOC)  ~ in sparse MDCK cells (Br6 et 
al.,  1990). As the cells form contacts, junctions assemble 
and polarization is induced (Gumbiner and Louvard,  1985). 
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During establishment  of cell polarity,  the centrioles split, 
migrate towards the apical pole of the cell, and the pericen- 
triolar material disperses;  simultaneously, the microtubules 
reorganize into bundles running parallel to the apical-basal 
axis, apparently no longer originating from the perinuclear 
region (Bacallao et al., 1989; Buendia et al., 1990; Gilbert 
et al.,  1991). 
Formation of cell-cell contacts is accompanied by stabili- 
zation of microtubules in epithelial  ceils, but not in fibro- 
blasts  (Pepperkok  et al.,  1990; Wadsworth and McGrail, 
1990). This stabilization appears to occur along the entire 
microtubule length (Br6 et al.,  1990). Stable microtubules 
often contain posttranslationally modified tubulin, but it has 
been suggested that acetylation and detyrosination are rather 
the result than the cause of microtubule stability (Webster et 
al.,  1990; Br6 et al.,  1987). Thus,  other factors,  such as 
microtubule-associated  proteins (MAPs), must be involved 
in the initial events of microtubule stabilization. 
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neuronal MAPs, little is known about the precise function 
of MAPs in mammalian nonneuronal cells. Apart from the 
well characterized microtubule-based molecular motor pro- 
teins  kinesin  and  cytoplasmic  dynein,  which  are  not  ex- 
pected to have  structural  functions,  relatively  few MAPs 
have been characterized so far in these cells. MAP4 desig- 
nates a group of ubiquitous proteins of ~ 200 kD (Olmsted 
et  al.,  1986),  initially  identified  as  210-kD  HeLa  MAP 
(Bulinski and Borisy,  1979),  murine  MAP4 (Olmsted and 
Lyon, 1981),  and bovine MAP-U (Murofushi et al.,  1986). 
They belong to a family of proteins originating from alterna- 
tively spliced mRNA which are differentially expressed in 
various tissues (West et al.,  1991).  MAP3  (180  kD),  first 
identified in astroglia and neurons (Huber et al.,  1985) and 
subsequently  detected  in  various  nonneuronal  rat  tissues, 
might also be a member of the MAP4 family (Huber and Ma- 
res,  1990).  Chartins  constitute another  complex family of 
MAPs  (Duerr  et  al.,  1981;  Magendantz  and  Solomon, 
1985). The functions of these two protein families are un- 
known.  Several additional  "MAPs" (~200,  151, 125,  114, 
,,o100, and 68 kD) have been identified in HeLa cells (Bulin- 
ski and Borisy, 1979; Weatherbee et al.,  1980); they are so 
far only poorly characterized. 
Microtubule-associated proteins were initially defined and 
purified by their ability to copurify with microtubules during 
cycles of polymerization  and  depolymerization.  Many  of 
them promote tubulin polymerization in vitro. They usually 
interact rather stably with microtubules and have therefore 
been implicated in regulation of microtubule stability. Over- 
expression  of  neuronal  MAP'2  and  tan,  but  not  of  the 
microtubule-based  motor  protein  kinesin  (Navone et al., 
1992), leads to bundling and stabilization of microtubules in 
normeuronal cells (Lewis et al.,  1989; Lee and Rook, 1992; 
Kanai  et  al.,  1992).  Microinjection  of purified  tau  into 
fibroblasts also stabilizes microtubules (Drubin and Kirsch- 
ner,  1986). Additional approaches have recently been used 
to identify novel microtubule-bindlng proteins. A doublet of 
95 and 105 kD proteins has been identified in CHO cells by 
raising antibodies against isolated mitotic spindles (Selitto 
and Kuriyama,  1988),  and an antigenically  cross-reacting 
doublet of 100 and 115 kD was found in HeLa cells (Nislow 
et al., 1990). Although these proteins do not display the typi- 
cal nucleotide-sensitive microtubule-binding characteristics 
(Nislow et al.,  1990), one of them has recently been pro- 
posed to belong to the class of molecular motors (Nislow et 
al., 1992). A 170-kD protein (CLIP-170) has been identified 
in HeLa cells by its cosedimentation with taxol-polymerized 
microtubules (Rickard and Kreis,  1990,  1991). CLIP-170 is 
involved in the interaction of endosomes with microtubules 
(Pierre  et al.,  1992).  It also accumulates  at desmosomal 
plaques in polarizing epithelial cells (Wacker et al.,  1992). 
CLIP-170 may thus link microtubule plus-ends to other cyto- 
plasmic  structures  and  thereby  play  a  role  in  regulating 
microtubule stability. 
Several neuronal MAPs are expressed differentially during 
development, probably correlating with their functional prop- 
erties (Matus,  1988). It might also be expected that specific 
MAPs are involved in microtubule stabilization during epi- 
thelial cell polarization,  and in the (re)organization of cyto- 
architecture, but so far, no epithelial cell-specific MAP has 
been identified. Here we characterize a novel MAP with an 
apparent  molecular  weight of 115,000  (E-MAP-115),  pre- 
dominantly expressed in cells of epithelial origin, which may 
be a candidate for a protein regulating microtubule stability 
and reorganization  during cell polarization. 
Materials and Methods 
Preparation of  HeLa Microtubule-binding Proteins 
HeLa-S3 cells were grown in suspension in Joldik's MEM supplemented 
with 1% glutamine, penicillin and streptomycin, as well as 5% new born 
calf serum, at 37°C in air to a density of 6  x  l0  s cells/ml. Cells were spun 
for 10 rain at 500 g, washed twice in Hanks buffer at 4°C, and once in 100 
mM KPipes, 1 mM EGTA, 1 mM MgSO4,  pH 6.8 (PB). The washed cells 
were resuspended in 1 mi/mi of pellet in PB with 1% Triton X-100,  I mM 
DTT and 1 mM PMSF and lysed for 30 rain on ice. The lysate was spun 
for 10 rain at 4°C at 12,000 g in a SS-34 rotor (Sorvall Instrs. Div., Nor- 
walk, CT) and the supernatant centrifuged for 1 h at 150,000 g in a Ti-70 
rotor (Beckman Instrs., Fullerton, CA) at 4°C. This high-speed supernatant 
was incubated for 20 rain at 370C with 30/zg/mi of  purified calf brain tubu- 
lin, prepared as described (Mitchison and Kirschner, 1984),  and 20 ttM 
taxol (a generous gift of the Drug Synthesis and Chemistry Branch, Divi- 
sion of Cancer Treatment, National Cancer Institute, Bethesda, MD) to 
promote microtubule polymerization. 1 U/ml apyrase was added for an ad- 
ditional  20  rain  at  37°C  to  increase  binding  of  nucleotide-sensifive 
microtubule-binding proteins. Microtubules from this solution were then 
sedimented through a cushion of 4 M glycerol in PB with 2 #M taxol and 
1 mM DTT for 30 rain at 30000 g at 30°C in a  SW27 rotor (Beckman 
Instrs.), and washed once in PB with 10 t~M taxol and 1 mM DTT.  The 
microtubule-binding proteins were eluted by resuspending the pellet in PB 
with 0.8 M NaCI, 10 mM MgATP,  10/~M taxol, and 1 mM DTT. This sus- 
pension was finally spun at 80,000 g for 30 min at 30°C in a TLA100 rotor 
(Beckman  Instrs.).  The  supernatant  containing the crude  microtubule- 
binding proteins was used to immunize rabbits. 
cDNA Expression Library Screening with Antisera 
A  mixture of antisera from eight different bleedings of two rabbits im- 
munized with HeLa cell microtubule-binding proteins was used to screen 
'~200,000 colonies of a random-primed HeLa cell eDNA library prepared 
in the expression plasmid pUEX (Bressan and Stanley, 1987).  The fusion 
proteins expressed by the positive clones were used to affinity-purify anti- 
bodies from the mixture of  sera on nitrocellulose blots as described (Rickard 
and Kreis, 1990). 
Antibodies 
An E-MAP-115  fusion protein (produced by clone pi/125, corresponding to 
aa 245-749) was purified by SDS-PAGE. The acrylamide gel piece contain- 
ing the protein was washed with PBS, homogenized, and emulsified into an 
equal volume of complete Freund's adjuvant (GIBCO BRL, Galthersburg, 
MD). Soluble fusion protein, for intravenous injections of mice, was ob- 
tained by electro-elution from the gel as described 0Bhown et al.,  1980). 
Immunization of mice was done according to Allan and Kreis (1986). 
Mouse spleen cells were used for production of mAbs and positive clones 
were identified in a first round by immunofluoresccnce  on HeLa cells (Allan 
and Kreis, 1986) and in a second round by immunoblotting on total HeLa 
cell lysates. Rabbits were immunized with peptides and antibodies were 
afffinity-purified as described (Duden et al.,  1991). 
Cell Culture 
Vero, HeLa, Caco-2, and MDCK cells, as well as human skin fibroblasts, 
were grown in MEM. A72 tumor-derived dog flbroblaats (Binn et al., 1980) 
were grown in L-15 (Leibovitz) medium. All media were supplemented  with 
2 mM L-glutamine, 100 U/ml penicillin, 100 t*g/ml streptomycin, as well 
as 5%  (MDCK, Veto), 10%  (HeLa, A72, human skin fibroblasts), 20% 
(Caco-2) FCS. The HeLa, Caco-2, and human skin fibroblast media also 
contained 1% non-essential amino acids. Cells were grown with 5 % CO2 
at 370C  in humidified incubators. 
Immunofluorescence 
Cells grown on coverslips were fixed for 4 rain in methanol at  -20°C, in 
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mM MgCI2, 0.5% Triton X-100, pH 6.8, as described (Kreis,  1987). Alter- 
natively, in experiments not shown, cells were fixed by para-formaidehyde 
(Duden et al.,  1991) or ghtaraldehyde (Buendia et ai.,  1990). Fixed cells 
were labeled with mouse mAbs against E-MAP-115 (D9C1 or D6B2) or the 
mycl-9E10 epitope (Evan et al., 1985) and with rabbit polyclonal antibodies 
specific for tyrosinated tubulin (anti-T13; Kreis, 1987). Epifluorescence  mi- 
croscopy  was performed using a Zeiss 63x  Planapo, 1.4 or a Zeiss 40x 
Plan-Neofluotar oil immersion objective on a Zeiss Axiophot microscope, 
and images were recorded on Kodak T-Max P3200 film. 
Immunogold Labeling for Electron Microscopy 
HeLa cells grown on glass coverslips were fixed for 4 rain in methanol at 
-20°C and incubated twice for 2 h with an anti-E-MAP-115 mAb (DdB2 
or D9C1). Three washes of 10 rain with 0.5% BSA in PBS were followed 
by incubation with goat anti-mouse antibodies coupled with 10-nm colloi- 
dal gold (AuroProbe EM GAR G10; Amersham Corp., Arlington Heights, 
IL) for 2 h at 37°C. Additional washes included three times 10 rain in 0.5 % 
BSA in PBS and three times 5 min in PBS. After fixation and further pro- 
cessing,  the specimen was done as described (Wacker et al.,  1992). 
Electrophoresis and Immunoblotting 
Gel electrophoresis and immunobiotting was done as described (Rickard 
and Kreis,  1990). 
Sedimentation of  E-MAP-115 with Microtubules 
200/~1 of HeLa cytosol ('~8 mg/ml) was incubated at 37°C for 30 rain with 
different additions.  The samples were loaded on a 480/~l 10 % sucrose cush- 
ion in PB with 1 mM DTT and 2/zM taxul. After a 30-rain centrifugation 
at 30,000 g in a SW50 rotor (Beckman Instrs.), the pellets were analyzed 
for the presence of E-MAP-115 by immunoblotting. 
cDNA Cloning and Subcloning of  E-MAP-115 
The 19 clones obtained by screening ofa HeLa cDNA library in pUEX were 
shown to be related by Southern blotting and by restriction mapping. To ob- 
tain the complete cDNA sequence,  a restriction fragment of •700  bp from 
the Y-end of clone pi/44 (bases 576-2,650) was labeled with 32p using the 
Random-Primed Labeling kit (Boehringer Mannheim, FRG) and used as a 
probe to screen 350,000 clones of a HeLa cell cDNA library in the vector 
k ZAP II (kindly provided by Dr. P. Chambon, Strasbourg).  This library 
was screened twice more and the pUEX library once more with ,~300 bp 
fragments from the Y-ends of the most 5"extending clones sequentially ob- 
tained. After transfer of  bacterial colonies or phages onto nitrocellulose,  the 
filters were processed according to Sambrook et al. (1989).  Prehybridiza- 
tions and hybridizations  were performed at 68°C. The air-dried filters were 
exposed to X-ray  films  (X-Omat AR; Eastman Kodak,  Rochester,  NY). 
DNA isolation from transformed bacteria and recombinant  DNA manipula- 
tions were performed using standard procedures (Sambrook et al.,  1989). 
The  inserts  of  the  pUEX  clones  were  subcioned  into  the  plasmid 
BLUESCRIPT KS (Stratagene,  La Julia, CA).  Clones obtained from the 
ZAP II library were excised as BLUESCRIPT SK plasmid with a helper 
phage according to the manufacturer's instructions and plasmid DNA was 
analyzed further. 
cDNA Sequencing 
Three clones (pi/44, bases 576-2,650; zI/51, bases 167-1,154; zII/62 bases 
149-1,989)  were used for bidirectional deletions using a Nested Deletion 
kit (Pharmacia-LKB,  Freiburg, FRG) for DNA sequencing.  Several other 
clones were sequenced on one strand with oligonucleotides  as sequencing 
primers. The two most extreme clones (pH/49, pIF4) were sequenced with 
oligonucleotides  on both strands. Plasmid DNA, purified on Qiagen col- 
uums (Diagen GmbH, Dfisseldorf,  FRG), was used for dideoxynucleotide 
sequencing with (ot35S) dATP and a T7 sequencing kit (Pharmacia-LKB) 
or with fluorescent primers and the EMBL sequencing device. The cDNA 
corresponding to the 5' non-coding region and the open reading frame 
(ORF) was sequenced at least twice in both directions, the 3' non-coding 
region at least once on both strands. Sequence data were compiled and ana- 
lyzed using the UWGCG package  as described by Duden et al. (1991). 
Sequence Analysis and Structure Prediction 
The secondary structure prediction, the molecular weight, and amino acid 
composition  of  E-MAP-115  were  obtained  using  the  GCG-programs, 
PEPTIDE-STRUCTURE and PEPTIDESORT  (Devereux  et ai.,  1984). 
FASTA (Pearson and Lipman,  1988) and BLAST (Altschul et ai.,  1990) 
were used to search the GenEMBL nucleotide data library (release 34.0) 
and the SwissProt protein data library (release 24.0) for sequences homolo- 
gous to E-MAP-ll5. Comparison of E-MAP-115 with the so far character- 
ized microtubule-interacting  proteins was also done using the Sensitive Se- 
quence Comparison program (ISSC; Rachid et ai.,  1989). 
In Vitro Transcription and Translation 
The different templates in BLUESCRIFr were linearized at convenient re- 
striction sites and RNAs were produced by in vitro transcription using T3 
polymerase and an in vitro transcription kit (Promega Corp., Madison, WI) 
according to the manufacturer's instructions. RNAs were subsequently used 
for translation  using a rabbit reticulocyte lysate (Promnga Corp.) for 60 min 
at 30°C using [35S]methionine (Sambrook et al.,  1989). 
Immunoprecipitation 
[35S]Methionine-labeled protein was obtained either by in vitro transcrip- 
tion/translation  with clone pIF49 as template or overnight labeling of HeLa 
cells with 100 mCi [3SS]methionine and lysis in 20 mM Tris,  100 mM 
NaCI, 0.4%  SDS,  1/tM PMSF, pH 7.4 frx-loo was added to a final con- 
centration of 2% to dilute out the SDS).  The in vitro translation reaction 
and the lysate were spun at 150,000 g for 1 h and at 15,000 g for 15 rain, 
respectively, at 4°C, and the supernatants were used for immunoprecipita- 
tion with the mAb D9C1 according to Rickard  and Kreis (1991). The im- 
munoprecipitates were analyzed by 8% SDS-PAGE. The gel was incubated 
in 1 M sodium salicylate  for 30 rain, dried, and exposed  to X-Omat AR 
films (Eastman Kodak). 
Generation of  Mutant cDNA Clones 
The cDNA coding for mutant Mal cDNA was constructed by digestion of 
clone plI/49 with NheI and HpaI, treatment by nuclease S1 and religation. 
Clones were sequenced, and one with the same reading frame as the original 
clone was selected for transcription and subsequent in vitro translation. In 
this clone, base 327 (numbering corresponds to the sequence shown in Fig. 
6 B) is ligated to base 784 giving rise to a protein lacking residues 77-228. 
To construct the Mb mutant, a novel NheI site was introduced at base 1,382 
by PCR and used for ligation with the original NheI site. To generate the 
NheI site, the oligonucleotides  5'CCCTGCTGCGCTAGCCATGG3'  (bases 
1,369-1,388;  substituted bases underlined) and 5'GCTATCCAGTCTGTT- 
GTY, corresponding to the antisense oligonucleotide  of bases 2,500-2,516, 
were used as primers with clone pi/44 as a template.  The PCR product was 
cut by NheI and XbaI and ligated with clone pIF49 digested by NheI and 
XbaI (XbaI from the linker). The resulting cDNA was fully sequenced with 
oligonucleotides  as primers. The corresponding protein Mb lacks amino 
acids 81--426. The cDNAs coding for P2 and Ma2 were made by cutting 
clone pII/49 and the cDNA coding for Mal, respectively,  by XbaI. The 
cDNA coding for P3 was obtained by cutting clone pH/49  at a SacI site. 
To attach the mycl-9El0 epitope (Evan et ai.,  1985) to the NH2-terminus 
of the encoded P3 polypeptide,  clone pIF49 had previously been ligated to 
the cDNA encoding this epitope via an NdeI site. This NdeI site had been 
created in the clone plI/49, at the bases encoding the first methioulne, by 
PCR. The vector containing the myc epitope was constructed and kindly 
provided by Dr.  V. Olkkonen (EMBL, Heidelberg). 
In Vitro Microtubule-binding Assays with In Vitro 
Translated Polypeptides 
27/tt of in vitro translation reaction containing 30/tCi of [3SS]methionine 
were diluted in PB in a final volume of 210/~1 with a final concentration 
of 1 mM cold methionine and 1 mM PMSE After 30 rain on ice, the reac- 
tion mixture was spun at 55,000 rpm for 60 rain at 4"C in a TLA-100 rotor 
(Beckman Instrs.). 100/~1  of  the supernatant were incubated with or without 
30 t~g of taxol-polymerized microtubules (Rickard and Kreis,  1990) for 30 
min at 37°C  in the presence of either 20/~M taxol or 40 ttM nocodazole 
and loaded on 560/~1 of 10% sucrose in PB. After 30 rain centrifugetion 
at 30000 g at 30"C in a SW50 rotor (Beckman Instruments), equal amounts 
of the supernatants and pellets were analyzed by 8% SDS-PAGE and the 
gel subsequently treated for fluorograpby  as above. 
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cence localization of E-MAP- 
115. HeLa cells (A and B) and 
human skin fibroblasts (C and 
D) were fixed in methanol  af- 
ter  detergent  preextraction. 
Double  immunofluorescence 
labeling  was  performed with 
mAb D9C1  against  E-MAP- 
115  (A and  C)  and a  rabbit- 
tubulin  antiserum (B and D). 
Images  were  taken  as  de- 
scribed  in  Materials  and 
Methods with exposure times 
for E-MAP-I15 labeling of 8 s 
for HeLa ceils (A) and 25 s for 
human  skin  fibroblasts  (C). 
Staining for E-MAP-115 is ob- 
served on segments or subsets 
of microtubules  near the nu- 
cleus (A and C). Only a small 
subset of microtubules is posi- 
tive  for E-MAP-I15 in fibro- 
blasts  (C).  Bar,  20 #m. 
Transient Transfection  of Veto Cells 
Clone pii/49 and the clones encoding  polypeptides P3, Mal, and Mb were 
subcloned into an SV-40  expression vector  pSG5 (Green  et al., 1988). Plas- 
mid DNA used for transfection was purified on a Qiagen column and dia- 
lyzed against 1 mM EDTA, 10 mM Tris, pH 7.5. Vero cells were split 
24 h before transfection so that they were •80%  confluent  on the day of 
transfection. The cells were washed twice with serum-free medium and 
transfected with DOTAP (Boehringer, Mannheim) according  to the manu- 
facturer's instructions with the following  modifications. The transfection- 
reagent-DNA  mixture was added directly  to cells for 2 min and then diluted 
with serum-free  medium. After 4 h, the medium was replaced by medium 
containing  5 % FCS. Cells were  processed for immunofluorescence  staining 
after 20 h. 
Results 
Identification of  E-MAP-115 
Antisera raised against crude microtubule-binding proteins 
from HeLa cells were used to screen a HeLa cell cDNA ex- 
pression library to identify and clone novel MAPs.  Clones 
encoding fragments of already characterized proteins likely 
to be recognized by the sera were identified in a first round 
using  a  mixture  of murine  mAbs against  tubulin,  MAP4, 
CLIP-170, vimentin,  and actin.  Approximately 500 clones 
were detected and not further characterized.  95 new clones 
were identified in the second round with a mixture of  the rab- 
bit antisera against HeLa microtubule-binding proteins. An- 
tibodies were affinity-purified on fusion proteins expressed 
by the different clones and used to group the clones into im- 
munologically related families, to localize the corresponding 
cellular proteins  by immunofluorescence and to determine 
their  Mr by  immunoblotting  of cell  lysates.  Four  families 
were obtained by this  approach:  52  clones encoding frag- 
ments  of a  protein  of ~  200  kD  (related  to  MAP4);  two 
clones encoding fragments of a  70-kD protein (non-specif- 
ically cosedimenting with microtubules);  22 clones encod- 
ing fragments of a protein of--170 kD (affinity-purified anti- 
bodies cross-react with CLIP-170); and 19 clones encoding 
fragments of a protein with an apparent Mr of 115,000. This 
latter protein (termed E-MAP-115) was characterized further 
using monoclonal and affinity-purified polyclonal antibodies 
prepared  against a  fusion protein corresponding to a  frag- 
ment of E-MAP-115  (clone pi/125). 
E-MAP-115 Is Associated with Subdomains 
of  Microtubules 
E-MAP-115 colocalizes with microtubules in HeLa cells and 
human skin fibroblasts (Fig.  1). E-MAP-115 is preferentially 
localized on microtubules in the perinuclear region in HeLa 
cells (Fig.  1 A). In the skin fibroblasts,  labeling for E-MAP- 
115  is  significantly  weaker  and  restricted  to  only  a  few 
microtubules (Fig.  1 C).  No labeling was detected in Vero 
(monkey  fibroblast)  cells.  The  intensity  of  labeling  for 
E-MAP-115  along microtubules  is  gradual  and diminishes 
towards their peripheral ends.  This labeling pattern is inde- 
pendent of the method of cell fixation (para-formaldehyde, 
glutaraldehyde, or methanol, with or without detergent pre- 
extraction; not shown). The distribution of E-MAP-115 is in 
contrast to that of MAP4 and the 125-kD HeLa MAP, which 
are present on virtually all microtubules and label continu- 
ously along their entire length (Bulinski and Borisy, 1980b). 
Furthermore, labeling for E-MAP-115 is heterogenous within 
the same population of cells  (Fig.  3 A).  In the fibroblasts, 
some of the microtubules in the perinuclear area containing 
E-MAP-115  are  curly.  Such  microtubules  frequently  cor- 
respond to a  subset of stabilized  microtubules enriched in 
detyrosinated Glu-tubulin (Schulze et al.,  1987; Webster et 
al.,  1987; Kreis,  1987).  Labeling for Glu-tubulin to corre- 
late E-MAP-115 localization with microtubules enriched in 
Glu-tubulin revealed that only few Glu-microtubules existed 
in the fibroblasts; they were all positive for E-MAP-115, but 
not all  E-MAP-115-positive microtubules  were labeled  for 
Glu-tubulin  (not  shown).  Thus,  E-MAP-115  could  be  in- 
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microscopic  localization  of 
E-MAP-115. HeLa cells grown 
on glass coverslips were meth- 
anol-fixed  and  labeled  with 
mAb D6B2 and 10-nm gold- 
conjugated  secondary  anti- 
bodies  before  embedding  in 
plastic  for  electron  micros- 
copy.  Numerous  gold  par- 
ticles  are  found  along  mi- 
crotubules  (arrowheads).  A 
microfilament bundle which is 
not labeled is indicated by an 
arrow  (B).  Numerous  inter- 
mediate filaments, which are 
not labeled,  can also be ob- 
served. Bar, 200 nm. 
volved in stabilizing microtubules and rendering them more 
susceptible to the slowly acting carboxypeptidase (Argarana 
et al.,  1978).  This hypothesis is  consistent with previous 
data  suggesting  that  microtubules  are  stabilized  before 
detyrosination (Webster et al.,  1990; Br6 et al.,  1987). 
The specific association of E-MAP-115 with microtubules 
in  vivo  was  confirmed  by  immuno-electron  microscopy 
using a preembedding labeling procedure on methanol-fixed 
HeLa cells (Geuens et al., 1983). "o85 % (95) of  the colloidal 
gold particles were within 50 nm of microtubules (arrow- 
heads in Fig. 2, A and B); the remaining particles were as- 
sociated with nonidentified structures. No E-MAP-115 was 
detected on intermediate or actin filament bundles. 
The association of E-MAP-115 with microtubules in HeLa 
cells was further analyzed using microtubule-active drugs. 
Prolonged treatment of HeLa cells with nocodazole induces 
depolymerization of most  microtubules  and  concomitant 
dispersal and solubilization of E-MAP-115 (Fig. 3, A and B); 
preextraction of these cells with detergent before fixation 
results in the disappearance of soluble E-MAP-115 and tubu- 
lin  and  reveals remaining  clusters  of randomly nucleated 
microtubules which always contain E-MAP-115  (Fig.  3,  C 
and D). Interestingly, it appears that the number of microtu- 
bules  resistant  to  treatment  of cells  with  nocodazole to 
depolymerize microtubules  correlate with  the  amount  of 
E-MAP-115 expressed in the cells (Vero <  HeLa <  Caco-2, 
MDCK;  not shown). 
In nocodazole wash-out experiments, E-MAP-115 initially 
labeled the regrowing microtubules along their length (not 
shown). This observation suggests that E-MAP-115 is pres- 
ent  at  non-saturating  levels in  HeLa cells  since  it labels 
microtubules uniformly when they are reduced in number 
and total length. This is supported by the observation that 
E-MAP-115 cannot be detected in HeLa cytosol by immuno- 
blotting after sedimentation of taxol-polymerized microtu- 
bules, whereas it all remains in the supernatant in the ab- 
sence  of tubulin  polymerization with  taxol  (not  shown). 
Treatment of cells with vinblastine induces the formation of 
tubulin paracrystals which are intensely labeled with anti- 
bodies against E-MAP-115 (Fig. 3, E and F). E-MAP-115 is 
also associated with taxol-stabilized microtubules, but in- 
creasing  microtubule  stability  by treatment  of cells  with 
taxol (up to 3 h) did not significantly increase the proportion 
of microtubules  labeled  for the  protein  (not  shown).  No 
change in  distribution of E-MAP-115  was observed when 
microfilaments were depolymerized with 1 #M cytochalasin 
D  for 1 h at 37°C, further suggesting that the protein does 
not interact with actin in vivo (not shown). A possible inter- 
action of E-MAP-115 with intermediate filaments in vivo was 
also ruled out by microinjection into HeLa cells of a mono- 
clonal antibody against vimentin (7A3) which collapses in- 
termediate filaments (Matteoni and Kreis, 1987). The distri- 
bution of E-MAP-115  was not affected in these cells,  and 
E-MAP-115  did  not colocalize with  the aggregated inter- 
mediate filaments (not shown). Taken together, these experi- 
ments  confirm that  E-MAP-115  is  specifically associated 
with microtubules and does not interact with either actin or 
intermediate filaments. 
Comparison of  E-MAP-115 with Other 
Microtubule-binding Proteins 
The  microtubule-binding  characteristics  and  biochemical 
properties of E-MAP-115  were investigated to compare it 
with  previously  described  proteins  of  similar  molecular 
weight. HeLa cytosol was incubated with taxol to polymer- 
ize endogenous tubulin in the presence of either ATP, GTP, 
AMP-PNP,  or an ATP-depleting system, and the microtu- 
Masson and Kreis A Novel MAP Predominantly Expressed in Epithelial Cells  361 Figure 3. Effects of microtubule-active drugs on the distribution of E-MAP-115. HeLa cells were incubated with 10 #M nocodazole  for 
90 min at 37°C (A-D), or with 10 #M vinblastine  for 3 h at 37°C (Eand F). Ceils were fixed in methanol (A, B, E, and F) or in methanol 
after detergent  preextraction  (C and D).  Double immunofluorescence labeling was performed with mAb D9CI against E-MAP-I15  (A, 
C, and E) and a rabbit-anti-tubulin  antiserum (B, D,  and F). The few stable remaining microtubules in nocodazole-  and the tubulin 
paracrystals in vinblastine-treated ceils are heavily labeled for E-MAP-115. Bar, 20 tzM. 
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E-MAP-115 with mierotubul~. 
HeLa cytosol  was  incubated 
with 20 #M noeodazole for 30 
rain at 37"C (lane 1) or 10 #M 
taxol (lanes 2, 3, 4, 5, and 6) 
without additions (lanes 1 and 
2),  or with 4  U/ml  apyrase 
(lane  3),  5  mM  AMP-PNP 
(lane 4), 5 mM MgATP (lane 
5),  or 5  mM  MgGTP  (lane 
6).  The  samples were  then 
sedimented through a 10% su- 
crose cushion and the pellets 
analyzed by  SDS-PAGE and 
silver staining (A) and immu- 
noblotting with mAb (D9C1) 
against E-MAP-115 (B).  The 
samples were also tested with 
antibodies against actin (act) 
and tubulin (tub; not shown); 
the positions of these proteins 
are indicated by the  arrows. 
The total high-speed superna- 
tant  (HSS),  HeLa  cytosol, 
was  also  analyzed.  Molecu- 
lar  weights  are  indicated 
(x 10-3). 
bules were sedimented through sucrose. E-MAP-115 cosedi- 
ments with microtubules under all these conditions, showing 
that  its  binding  to  microtubules  is  nucleotide-insensitive 
(Fig.  4).  This  indicates  that  E-MAP-115  is  distinct  from 
kinesin (120 kD; Brady, 1985; Vale et al.,  1985) and dyna- 
min (100 kD; Shpetner and Vallee,  1989), proteins of similar 
molecular weight.  E-MAP-115  appears  to  interact tightly 
with microtubules since concentrations of >0.5 M NaC1 had 
to be used to elute it, whereas MAP4 is completely eluted 
at <0.5 M NaCI (not shown). When HeLa cytosol was in- 
cubated with nocodazole to prevent tubulin polymerization 
several proteins (including acfin) sedimented through the su- 
crose cushion, but E-MAP-115 did not,  indicating that its 
sedimentation is microtubule-dependent. 
To further compare the sedimentation properties of these 
microtubule-binding proteins, HeLa cytosol was sedimented 
through a sucrose gradient and the fractions were analyzed 
by immunoblotting (not shown).  E-MAP-115  (and MAP4, 
Figure 5.  E-MAP-115 is detected 
in  epithelial  cells  but  not  in 
fibroblasts  by  immunoblotting. 
Total extracts of HeLa cells (1), 
Caco-2  cells  (2),  human  skin 
fibroblasts (3), MDCK cells (4), 
A72 dog fibroblasts (5), and Vero 
cells (6) were analyzed by immu- 
noblotting  for E-MAP-115 with 
mAb D9C1 (B). The correspond- 
ing  Coomassie-stained  gel  is 
shown in A.  Molecular  weights 
are indicated (x  10-3). 
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abundant in polarized Caco-2 
cells. Caco-2 cells (A-D) were 
preextracted  with  detergent, 
fixed in methanol and double- 
labeled  with  mAb  D9C1 
against  E-MAP-115 (A  and 
C),  and a rabbit-anti-tubulin 
antiserum  (B and  D).  Most 
microtubules  are  labeled  in 
the  sparse  Caco-2  cells. 
E-MAP-115 is most abundant 
in the polarized cells forming 
a blister in the left half of C 
and D. The plane of  focus in C 
and D is in the cells which are 
tightly  attached  to the  glass 
coverslip; the brightly labeled 
cells (slightly out of focus) are 
in domes which have detached 
from the  glass surface.  The 
difference in intensity of stain- 
ing between flat attached cells 
and ceils in blisters is signifi- 
cantly higher for E-MAP-115 
than for tubulin. Bar, 20/~m. 
CLIP-170, and tubulin; not shown) sediments at "~6 S, clearly 
different from the 125-kD HeLa MAP (14 S; Bulinski and 
Borisy,  1980a)  and  the mitotic spindle-associated protein 
doublet of ~110 kD (11 S; Selitto and Kuriyama, 1988; 100 
and 115 kD, Nislow et al., 1990), and kinesin (9.5 S; Bloom 
et al.,  1988). These results indicate that E-MAP-115 differs 
in molecular weight and sedimentation properties from the 
microtubule-binding proteins described so far. Furthermore, 
E-MAP-115  is  heat-denatured under conditions that  leave 
members of the MAP4 family apparently intact (Kotani et 
al.,  1988) (not shown). 
E-MAP-115 Is Predominantly Expressed in Cells of 
Epithelial Origin 
Since E-MAP-115 appeared more abundant in HeLa epithe- 
lial cells compared to fibroblasts, its presence and distribu- 
tion was studied in different cell lines of epithelial and fibro- 
blastic origin to obtain more information on the potential 
function of  this protein. By immunoblotting (Fig. 5), E-MAP- 
115  is  detected in the human  (HeLa, Caco-2) and canine 
(MDCK)  epithelial  cells,  but not in primary human  skin 
fibroblasts,  monkey Vero  cells,  and  A72  dog  fibroblasts. 
E-MAP-115 could not be detected in porcine brain extract 
(not shown). 
Antibodies  against  E-MAP-115  brightly  stain  microtu- 
bules in Caco-2  (Fig.  6,  A and  C) and  MDCK cells (not 
shown). Although human and dog fibroblasts appear nega- 
tive for E-MAP-115 by immunoblotting (Fig. 5, lanes 3 and 
5),  weak labeling (threefold longer exposure of film com- 
pared to epithelial cells) is detected on a few microtubules 
by immunofluorescence (Fig.  1  C).  Furthermore,  no sig- 
nificant labeling for E-MAP-115 was found in rat hyppocam- 
pal neurons (not shown).  When Caco-2 and MDCK cells 
start to polarize upon cell-cell contact formation, they de- 
tach from the substrate and form blisters (Fig. 6, C and D). 
There is a strong increase in labeling for E-MAP-115 in these 
polarized ceils, suggesting that E-MAP-115 expression levels 
increase with cell polarization (Fig. 6 C). In contrast, stain- 
ing for tubulin in these cells is only slightly brighter com- 
pared to  isolated  cells,  presumably because the cells are 
thicker (Fig. 6 D). This again demonstrates a correlation be- 
tween stabilized microtubules (abundant in polarized cells) 
and the presence of E-MAP-115. 
cDNA Cloning of  E-MAP-115 
A  family of 19  overlapping clones  (encoding bases  576- 
2,840 of the final eDNA for E-MAP-115) was obtained in 
the frst screening of a HeLa cell eDNA expression library 
with  antisera against  HeLa microtubule-binding proteins. 
The missing 5' eDNA was obtained by further screenings of 
the same and another eDNA library with restriction frag- 
ments from the 5' ends of the clones obtained initially (143 
clones were analyzed and partially or fully sequenced). The 
longest sequence obtained by the overlap of the two most ex- 
treme clones is shown in Fig. 7, A and B. No stop codon has 
been found at the 5' end of the longest ORF (bases 1-2,347). 
However, the  sequence  surrounding  the  first ATG  in  the 
ORE AGCACCA'IGG, conforms well with the consensus se- 
quence, GCC(A/G)CCATGG, for eukaryotic translation ini- 
tiation (Kozak, 1984). For this reason, and because among 
the many clones analyzed none was found to extend further 
in the 5' direction, we expected that this cDNA encoded the 
full-size protein.  In  vitro transcription and  translation of 
clone 49  (bases  69-3,120)  generated a  polypeptide of Mr 
115,000 (the major high molecular weight translation prod- 
uct)  which  comigrated  with  immunoprecipitated cellular 
E-MAP-115 (Fig. 7 C), suggesting that, indeed, this cDNA 
codes for the full-size protein. The protein with its first me- 
thionine encoded by the first in frame ATG codon has 749 
residues and a calculated molecular weight of 84,051.  The 
reason for the anomalous migration of E-MAP-115 on SDS- 
PAGE (apparent molecular weight of 115,000) is unclear so 
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1  GCGCTCACCTGTCTGGC4~CGCTGGC~C,~C~CGGCGGGAGCCAAGCCGAGG 
61  AAAGGGCGGAGCGGCTC  TCCGGGCGCGTCATCGGAGCACCATGGC  GGAGC  TAGGAGCTGG 
1  M  A  E  L  G  A  G 
121  C  GGC  GAC  GGC  CACAGGGGCGGCGACGGCGCAGTGCGAAGCGAAAC AGCAC  C  C  GAC  AGCTA 
8  G  D  G  H  R  G  G  D  G  A  V  R  S  E  T  A  P  D  S  Y 
181  CAAAGTGCAAGATAAGAAAAATGCCTCCAGCCGCCCTGC CTC  TGCAATTTCAGGAC  AAAA 
28  K  V  Q  D  K  K  N  A  S  S  R  P  A  S  A  I  S  G  Q  N 
241  TAACAACCACTCAGGAAATAAACCAGACC~CGCCTGT~ACGTGTTGATGACCGGCA 
48  N  N  H  S  G  N  K  P  D  P  P  P  V  L  R  ~/--~--[)--[~--~- 
301  GCGGCTGGCCCGGGAGCGACGTGAGGAACGGGAGAAACAGCTAGCTGCAAGAGAAATAGT 
68  "---L---A--'--'--'--'---'-'-'--'-'-',  L  A  A  R  E  I  V 
361  GTGGTTAGAAAGAGAAGAGCGAGCCAGGCAGCACTACGAGAAGCACCTGGAAGAGCGGAA 
88  W  L  E  R  E  g  R  A  R  Q  H  Y  E  K  H  L  E  E  R  K 
421  GAAGAGGTTGGAGGAGCAGAGGCAGAAGGAGGAGC GGAGGAGGGCTC~GGAGAA 
108  K  R  L  E  E  Q  R  Q  K  E  E  R  R  R  A  A  V  E  E  K 
481  GCGGAGGCAGAGACTTGAGGAGGACAAAGAACGCCACGAAGCTGTTGTACGGC  GCACAAT 
128  R  R  Q  R  L  E  E  D  K  E  R  H  E  A  V  V  R  R  T  M 
541  GGAAAGGAGC  CAGAAGCCAAAACAGAAGCATAACCGTTGGTCGTGGGGAGGCTCTCTCCA 
148  E  R  S  Q  K  P  KQ  K  H  N  R  W  S  W  G  G  S  L  H 
601  TGGGAGCCCTAGCATCCACAGTGCAGATC  C  AGACAGGCGGTCAGT~CACCATGAATCT 
168  G  S  P  S  I  H  S  A  D  P  D  R  R  S  V  S  T  M  N  L 
661  TTCGAAATATGTTGATCCCGTCA~'rAGC  AAGCGGCTL~CTCT'rCATCTGCAACq'rTACT 
188  S  K  Y  V  D  P  V  I  S  K  R  L  S  S  S  S  A  T  L  L 
721  AAATTCTCCAGATAGAG~GCCGCCTGCAGCTCAGCCCATGC, GAGAGCAGCGTTGTTAA 
208  N  S  P  D  R  A  R  R  L  Q  L  S  P  W  E  S  9  V  V  N 
781  CAGACTCCTGACGCCCACACATTCGTTC  C  TGGCCAGAAGTAAAAGCACAGCTGCCTTGTC 
228  R  5  L  T  P  T  H  S  F  L  A  R  S  K  S  T  A  A  L  S 
841  TGGAGAAGCAGCATCTTGCAGCCCCATCATCATGCCCTACAAAGCTGCACACTCTAGAAA 
248  G  E  A  A  S  C  S  P  I  I  M  P  Y  K  A  A  H  9  R  N 
901  TI~CGATGGATCGACCAAAACTCTTTGTAACACCACCTGAGGGCTCTI~CTCGCAGGAGGAT 
268  S  M  D  R  P  K  b  F  V  T  P  P  E  G  S  S  R  R  R  I 
961  CATTCATGGCACAGCGAGCTATAAAAAAGAAAGAGAGAGAGAAAATGTACTCTTCCTCAC 
288  I  H  G  T  A  S  Y  K  K  E  R  E  R  E  N  V  L  F  L  T 
1021  ATCTGGCACCCGAAGGGCTGTATCTCCATCTAATCCCAAAGCAAGACAACCAGCTCGCTC 
308  S  G  T  R  R  A  V  S  P  S  N  P  K  A  R  Q  P  A  R  S 
1081  CCGAC'~C  G'I~CAAGTC  TC~CTCAT'I~CTGGCACAC  C  CAGACCGACATC 
328  R  n  W  L  P  S  K  S  L  P  H  L  P  G  T  P  R  P  T  S 
1141  CTCCTTGCCACCCGGCTCAGTCAAAGCTGCTCCTGCTCAGGTCCGGCCCCCATCCCCCGG 
348  S  b  P  P  G  S  V  K  A  A  P  A  Q  V  R  P  P  S  P  G 
1201  CAACATCCGCCCTGTCAAGAGGGAAGTCAAAGTGGAGCCTGAGAAGAAAGATCCTGAGAA 
368  N  I  R  P  V  K  R  E  V  K  V  E  P  E  K  g  D  P  E  K 
1261  GGAAC  CTCAGAAAGTTGCC  AATGAGCCCTCACTAAAGGGCAGAGCACCTTTAGTGAAGGT 
388  E  P  Q  K  V  A  N  E  P  S  t  K  G  R  A  P  L  V  K  V 
1321  AGAAGAAGCCACAGTTGAAGAGCGGACACCTGCTGAACCAGAAGTTGGCCCTGCTGCTCC 
408  E  E  A  T  V  E  E  R  T | p  ~  ~  P  E  V  G  P  A  A  H 
1381  AGCCATGGCCCCAGCTCCAGC  CTCGGCCCCAGCTCCAGCCTCGGCCCCAGCTCCAGCCCC 
428  IA  bl  ~  P  A  P  ~  S  A  P  A  P  A  S  A  P  A  P  A  tl 
1441  GGTCCCCACCCCAGCCATGGTCTCAGCCCCGTCATCCACTGTGAATGCCAGTGCTTCTGT 
448  I  v  F  T  P  A  M  V  S  A  P|  S  S  T  V  N  A  S  A  S  V 
1501  TAAGACTTCTGCAGGCACC  ACCGACCCAGAGGAGGCCACAAGGCTTCTAGCTGAGAAGAG 
468  K  T  S  A  G  T  T  D  P  E  E  A  T  R  L  L--A--[£--T(--[~- 
1561  GCGC~CCGAGAGCAGAGAGAAAAC~C~GGGAGAGGAGGGAGCAGGAAGAGCT 
4a8  ,--,--,--,--,--,--,--,--,--,--,--,--,-  R  R  E  9  E  E  U 
1621  TGAAAGACAAAAGAGAGAGGAATTGC~AACGTGTGGCTGAAGAGAGGACGACTCGCCG 
508  E  R  Q  K  R  E  E  L  A  Q  R  V  A  E  E  R  T  T  R  R 
1681  TGAGGAGGAGTCGCGCAGGCTGGAAGCCGAGCAGGCCCGGGAGAAGGAGGAGCAGCTGCA 
528  E  g  E  S  R  R  L  E  A  E  Q  A  R  E  K  E  E  Q  L  Q 
1741  GCGGCAGGCGGAGGAGCGGGCGCTGCGCGAGCGGGAGGAGGCAGAGC GC  GC  C  C  AGAGGCA 
548  R  Q  A  E  E  R  A  L  R  E  R  g  E  A  E  R  A  Q  R  Q 
1801  GAAAGAAGAAGAAGCTCGCGTTCGTGAAGAAGCAGAGAGGGTC C  GGCAGGAAC  GAGAGAA 
568  K  E  E  E  A  R  V  R  E  E  A  E  R  V  R  Q  E  R  E  K 
1861  GCATTTCCAGAGAGAAGAGCAAGAGCGCCTGGAGAGAAAGAAGC GAC  TTGAGGAGATTAT 
588  H  F  Q  R  E  E  Q  E  R  L  E  R  K  K  R  L  g  E  I  M 
1921  GAAAAGAAC  CAGGAGAACAGAAGCTACAGATAAGAAAAC C  AGTGATCAGAGAAAC  GGTGA 
608  K  R  T  R  R  T  E  A  T  D  K  K  T  S  D  Q  R  N  G  D 
1981  TATAGC  CAAGGGAGCTCTCACTGGAGGAACAGAGGTGTCTGCACTTC CATG  TACAACAAA 
628  I  A  K  G  A  L  T  G  G  T  E  V  S  A  L  P  C  T  T  N 
2041  CGCTCCGGGAAATGGAAAGCCAGTTGGCAGCCCACATGTGGTTACCTCACACCAGTCAAA 
648  A  P  G  N  G  K  P  V  G  S  P  H  V  V  T  S  H  Q  S  K 
2101  AGTGACAGTGGAGAGCACTCCCGAT'I~CAAC  CAAATGA~TGGTGTATC TGT 
668  V  T  V  E  S  T  P  D  5  E  K  Q  P  N  E  N  G  V  S  V 
2161  TCAGAATGAAAA'I~*'*'LC,  AAGAAA~ATAAACTTAC  C  CATTGGATCTAAACCATCCAGATT 
688  Q  N  E  N  F  E  E  I  Z  N  L  P  I  G  S  K  P  S  R  L 
2221  AGATGTCACCAACAGTGAGAGCCCAGA~I~CCT'I'/'GAATCCAAT'I~GCCT TTGATGA 
708  D  V  T  N  S  E  S  P  E  I  P  L  N  P  I  L  A  F  D  D 
2281  TGAAGGGACACTTGGGCCCCTGCCTCAGGTAGATGG TGTTCAGACACAGCAGACTGCAGA 
728  E  G  T  L  G  P  L  P  Q  V  D  G  V  Q  T  Q  Q  T  A  E 
2341  AGTTATATGAGTGTTTCTTCTGAAGAACCAAAGCTGAAATTTAATGAGAATTTCTACAAT 
748  V  I  * 
2401  TAATGGAATTCCTTTCCTGCTATAAAGGAGCATC CCCTCCACCCG'x'I"r  I~CTAGAGTTC~ 
2461  GACCATCA'Lh'vt  C-AA~.GA~IWATTAAAACTAGCTAAAGACAACAGACTGGATAGCTTTT 
2521  CTAATAA'i-~-t  -tCATCAATAGGAAAAAAGAAATACGTCTCATTCTTCAATACTTTAAAATG 
2581  GC'I'I'I~I~CCAG~CT'I~AGCAATCAATA'FFvI'FCTGCAT'~AAAAGACAA 
2641  GAGAATTTGGTTATAAAAGAAATGGGCTGACTAGGCATGA't'I'I'I'rT'gGGTCTTAAAAGGC 
2701  TTAACATGTAAAATTGGCAAA~'FI'FI "J  "rACCTTTTATAATACTTGA~TAAGTA 
2761  CCT~ACAAGTAGAATGAATAGGAGAAGAGTTTAAGCCT~L'L't  "XTt'TAAAATA 
2821  TTATTGCAAAGAGCTCTATTTGTAGAAGCAAATTATAGGCAGATTACCAGGTTCTTATAA 
2881  ATACAGCTTGTACATGGACATTCTGCAAACCCAGCTGTCACAT~TTGCAACTCC'FF 
2941  TTGCAAAAGCAGACTAAAATG'~AAAATGTGA~CATTA'I"L'FL'L't ~2AAAGCAAGA 
3001  AAATAA~FI'gACTGCCCTCTTACATAATGTATTTATAAA~-,"L'L't  "t  "t  CCAGATAAACTAATCA 
3061  AATAAATTAGAATAATG~ACAACATTACAAAT'I~AAT'~CCA~X]GTACCTTCGT'I~C 
Figure  7.  cDNA  sequencing  of  E-MAP-115.  (A)  Schematic 
representation of the E-MAP-115 cDNA, constructed by the over- 
lap of clones plI/4 and pli/49, showing the restriction sites used and 
the open reading frame coding for E-MAP-115 (boxed region). N, 
NheI; S, Sad; H, HpaI; X,  XbaI; E, EcoRI. (B) Nucleotide and 
deduced  amino acid sequence of E-MAP-115.  The stop codon is 
marked with an asterisk. The PAPA-region, rich in alanine and pro- 
line, is boxed. The two putative 18-amino acid repeats are indicated 
with superscript dashed lines. Underlined amino acids correspond 
to  peptides  used  to  raise  antibodies.  These  sequence  data  are 
available from EMBL/GenBank/DDBJ  under  accession number 
X73882.  (C)  Comparison  of the in vitro translation product of 
clone  pII/49  with  cellular  E-MAP-115.  [3~S]Methionine-labeled 
E-MAP-115, translated in vitro using the cDNA clone pII/49 (1) or 
from Helm cells (2), was immunoprecipitated with mAb D9C1 and 
separated by SDS-PAGE. The autoradiogram shows that both pro- 
teins migrate with identical apparent molecular weights. Molecular 
weights are indicated (x  10-3). 
far. A  similar behavior has, however, also been observed for 
tan  (Lee  et  al.,  1988),  MAP2  (Lewis  et  al.,  1988),  and 
MAP4  (West et al.,  1991). 
Additional  evidence  supports  the  conclusion  that  this 
cDNA codes for full-size E-MAP-115 and that the first ATG 
initiates translation. The size of E-MAP-115 mRNA is •3.5 
kb (not shown), ,x,400 bases longer than the 3,120 bases of 
the cloned cDNA.  No poly(A) + tail is present in the cDNA 
sequence suggesting that a 3' extension is lacking.  Further- 
more, if the start methionine were further upstream to the 
one identified here,  the polypeptide  would increase in size 
by at least 33 aa, giving a difference in molecular weight be- 
tween the  in  vitro-translated  and the  HeLa  protein which 
should  be  detectable  by  SDS-PAGE.  In  addition,  cDNA 
clones starting shortly after the potential Kozak consensus 
sequence identified here do not yield good translation sug- 
gesting  that  this  consensus  sequence  is  likely  to  initiate 
translation. 
Polyclonal  antibodies  were  raised  against  four peptides 
deduced from the cDNA sequence (Fig.  7  B,  underlined); 
all react by immunoblotting with E-MAP-115.  This reaction 
is abolished by preincubating the sera with the correspond- 
ing peptides.  Staining  of calls  with  affinity-purified  rabbit 
antibodies raised against one of the peptides  (aa 667-682) 
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Figure 8.  Domain structure 
and  charge distribution pre- 
diction of E-MAP-115 and de- 
letion mutants. (A) The sec- 
ondary  structure  predictions 
and sequence analysis suggest 
that  E-MAP-115 can  be  di- 
vided into six main domains 
(top). The pI and percentage 
of charged amino acids were 
calculated for each of these 
domains.  (B)  Full-size and 
mutant E-MAP-115 constructs 
(names of constructs are indi- 
cated on the left) used to local- 
ize  its  microtubule-binding 
site. 
gives the same microtubule pattern as the mAb (recognizing 
a different epitope, localized between aa 427 and 550)  (not 
shown). These results confirm that the ORF used to predict 
the amino acid sequence is correct. 
Sequence Analysis and Comparison 
Searching the EMBL and SWlSSPROT data libraries with 
the  programs  FASTA  (Pearson  and  Lipman,  1988)  and 
BLAST (Altschul et al., 1990) did not reveal significant se- 
quence similarities between E-MAP-115  and the proteins 
present in these data banks. Pairwise comparisons were also 
performed to search for similarities with already character- 
ized MAPs using the sensitive homology search matrices 
(Argos, 1987). This analysis established that tau (Lee et al., 
1988),  MAP1B (Noble et al.,  1989),  MAP2 (Lewis et al., 
1988),  MAP-U (Aizawa et al.,  1990),  205 kD Drosophila 
MAP (Irminger-Finger et al.,  1990),  kinesin heavy chain 
from squid (Kozik et al.,  1990),  CLIP-170  (Pierre et al., 
1992), and dynamin (Obar et al., 1990) share no homology 
with E-MAP-115. 
The secondary structure and charge display of E-MAP-115 
were  predicted  using  the  program  PeptideStructure  (not 
shown). E-MAP-115 can be divided into six main regions ac- 
cording to this analysis (Fig. 8 A): the nearly neutral (pI 7.7) 
NH2-terminal  59 amino acids, a basic (pI  10.9) predicted 
a-helical region (aa 60-149) which is highly charged (66% 
charged residues), a poorly structured basic (pI 11.6) region 
(aa 150-416), an alanine/proline-rich region (PAPA region, 
aa 417--457, with 36.6% A, 34.1% P) which is acidic (pI 3.7), 
a second highly charged (65 % charged aa) predicted a-helical 
region (aa 477-619)  which is nearly neutral (pI 7.6),  and 
the acidic (pI 4.1) COOH terminus (aa 620-749). 
E-MAP-115 was also compared to itself  using the sensitive 
homology search algorithm (Argos, 1987). A sequence of 18 
amino acids (63-80 and 483-500) is repeated at the begin- 
ning of  the two highly charged regions with predicted oe-helical 
structure.  These repeats  show 67%  homology (V/L-D/A- 
D/E-R/K-Q/R-R-L-A-R-E-R/Q-R-E-E/K-R/E-E-K/R-Q/E; 
superscript dashed line in Fig. 7 B). The significance and 
role of this short repeat is not clear so far. 
Determination of the Microtubule-binding Region 
of  E-MA llS 
To characterize further the interaction of E-MAP-115  with 
microtubules,  we  attempted  to  localize the  mierotubule- 
binding site in an in vitro assay and by transfection into ceils 
using mutated eDNA (Fig. 8 B). The results of this analysis 
are summarized in Table I. Wild-type and mutant constructs 
were transcribed and translated in vitro, and the translated 
products were tested for their ability to cosediment with 
taxol-polymerized tubulin (Fig.  9,  Table  I).  The full-size 
protein (P1, 749 residues) binds efficiently to microtubules. 
P2 (aa  1-264)  and P3  (1-213)  bind to mierotubules when 
tested in vitro and in vivo, respectively, (Table I), implicating 
the basic,  highly charged NH2-terminal region with pre- 
dicted a-helical structure in the binding of E-MAP-115  to 
Table L Interaction of E-MAP-115 and Derived Mutants 
with Microtubules 
MT binding  MT stabilization 
Polypeptide  Deletions (aa)  in vitro  in vivo  in vivo 
P1  -  +  +  + 
P2  265-749  +  nd  nd 
P3  214-749  nd  +  + 
Mal  77-228  +  -  - 
Ma2  77-228/265-749  -  nd  nd 
Mb  81--426  -  -  - 
Binding of E-MAP-115 polypeptides to micrombules (MTs)  was analyzed  in 
vitro using a MT-binding assay (see also Fig. 8) and in vivo by transfection 
of Vero cells (see also Figs. 9 and 10).  MT stabilization  was tested by treating 
transfected cells with 10 #M nocodazole for 1 h (for details see Materials and 
Methods).  For the in vitro binding assays, "+" indicates 100%, "+" '~50%, 
and ~-" no binding; nd,  not determined. 
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tants to polymerized tubulin in vitro.  The microtubule-binding 
properties of full-size and mutant in vitro translated E-MAP-115 
(see Fig. 8 B) were tested in vitro (for details see Materials and 
Methods). 35S-labeled  polypeptides were incubated without (-) or 
with (+) taxol-polymerized tubulin. After centrifugation through 
a sucrose cushion, the supernatants (S) and pellets (P) were ana- 
lyzed by SDS-PAGE and fluorography. The relevant E-MAP-115 
polypeptides are indicated by arrows. A prominent nonspecific 
band, migrating with an apparent Mr of 55,000 is found in all of 
the in vitro translation reactions. Molecular weights are indicated 
(X  10-3). 
microtubules. This result is consistent with the notion that 
MAPs interact with microtubules via their basic domains. 
We further analyzed the role of this region in binding of 
E-MAP-115  to  microtubules by constructing mutant Mal 
with amino acids 77-228 deleted. This polypeptide partially 
binds to microtubules in vitro (,,o50%),  whereas Ma2 (Mal 
lacking aa 265 onward) does not. Mal transfected into Vero 
ceils (details see below), however, does not bind to microtu- 
bules in vivo (Fig. 11, Table I). We assume that microtubule 
binding of  mutant polypeptides expressed in Vero cells better 
reflects its native properties,  than when assayed in vitro, 
where a large excess of tubulin polymer over in vitro trans- 
lated  protein  is  used.  To  test  whether  the  other  highly 
charged region (pI 7.6) with a  predicted o~-belix interacts 
with microtubules, polypeptide Mb lacking residues 81-426 
(complete basic part of E-MAP-115)  was constructed. This 
polypeptide clearly does not interact with microtubules, nei- 
ther in vitro (Fig. 9) nor in vivo (not shown). We concluded 
therefore that a  microtubule-binding site of E-MAP-115  is 
in  the  NH2-terminal  basic  domain containing the  highly 
charged region with predicted t~-helical structure. We cannot 
exclude at this stage, however, that additional (weak) micro- 
tubule-binding site(s) are present in other regions of  E-MAP- 
115. Obviously, mutation of E-MAP-115 may result in (par- 
tial) denaturation of the corresponding polypeptide and thus 
"inactivatC functional domains. 
Microtubules in Cells Transfected with E-MAP-115  Are 
Stable to Nocodazole Treatment 
Since E-MAP-115 could not be detected in Vero fibroblasts, 
we used these cells for transfection experiments with (mu- 
tant)  E-MAP-115  to  further characterize its microtubule- 
binding domain and to study its effect on microtubule organi- 
zation in vivo. At low expression of transfected polypeptides 
(P1, P3), its distribution is very similar to the pattern of en- 
dogenous E-MAP-115 in HeLa cells; microtubules are posi- 
tive predominantly near the nucleus and staining is weaker 
towards their peripheral ends (Fig. 10 A). In cells expressing 
high levels of E-MAP-115, all the microtubules are positive 
for the protein along their entire length and a cytosolic pool 
of soluble protein appears (Fig. 10 C). Saturation of  binding 
of E-MAP-115  to microtubules impairs immunolabeling of 
tubulin (Fig.  10 D). Microtubules appear bundled to some 
extent and no longer predominantly centrosome nucleated. 
Microtubule bundling has also been observed with expres- 
sion of MAP2 and tau in nonneuronal cells (Lewis et al., 
1989;  Lee and Rook,  1992;  Kanai et al.,  1992) and it has 
been proposed that bundling is the general result of microtu- 
bule stabilization (Lee and Brandt, 1992). 
Since binding of  E-MAP-115 appears to correlate with sta- 
bilized  microtubules,  we  investigated the possibility that 
E-MAP-115  stabilizes microtubules by treatment of trans- 
fected Vero cells with nocodazole (Figs. 10 and 11; Table I). 
Nocodazole completely depolymerizes interphase microm- 
bules in the nontransfected cells, whereas in cells expressing 
intact E-MAP-115 (P1, Fig. 10), or the microtubule-binding 
site of E-MAP-115  (P3,  Fig.  11) numerous (individual or 
bundled) microtubules remain which are always positive for 
E-MAP-115. 
Incubation of epithelial cells with nocodazole is alone not 
sufficient to depolymerize all microtubules; additional cold- 
treatment is necessary (Bacallao et al.,  1989).  Transfected 
cells were therefore, in parallel experiments, incubated at 
0°C to depolymerize microtubules. No significant  difference 
in microtubule stability could be detected in the transfected 
and  non-transfected  cells  (not  shown),  indicating  that 
E-MAP-115 stabilizes microtubules to nocodazole but not to 
cold treatment. E-MAP-115  is therefore unlikely to be re- 
lated to the STOPs (stable tubulin only polypeptides) which 
make microtubules resistant to cold, Ca  2+, and microtubule 
active drugs (Job et al.,  1987). 
Discussion 
We have characterized  E-MAP-115,  a  novel microtubule- 
associated protein, at the molecular level. It is distinct from 
previously described microtubule-interacting proteins and 
has no homology to any other protein in the data banks. The 
organization  of  the  charged  regions  of  E-MAP-115  is 
reminiscent of, yet inverse to, that of several other MAPs. 
The NH2-terminal half of the protein has a high pI and is 
separated from the rather acidic COOH-terminal half by a 
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E-MAP-115  into  Vero cells 
stabilizes microtubules to de- 
polymerization with  nocoda- 
zole.  Vero ceils  were  trans- 
fected with cDNA coding for 
full-length E-MAP-I15. After 
20 h, cells were either directly 
fixed in  methanol  (A-D)  or 
first  treated  with  10  #M 
nocodazole for 1 h to depoly- 
merize  the  microtubules  (E 
and F) and double labeled for 
E-MAP-115 with mAb D9C1 
(A, C, and E) and tubulin with 
a rabbit polyclonal antiserum 
(B, D, and F). Nontransfected 
Vero cells  are  negative for 
E-MAP-115. At  low  expres- 
sion levels (A and B), E-MAP- 
115 is found on microtubules 
near  the  nucleus,  similar 
to what  is  observed  for en- 
dogenous E-MAP-115 in HeLa 
cells. At higher levels of ex- 
pression (C and D), E-MAP- 
115 labels the whole length of 
all microtubules (accessibility 
of antibodies  to  tubulin  ap- 
pears reduced in these cells). 
Single  or  bundled  microtu- 
bules in Vero cells expressing 
E-MAP-I15  are  resistant  to 
depolymerization with noco- 
dazole (E and F). Bar, 20 #m. 
stretch of amino acids  rich in proline and alanine  (PAPA- 
region). MAP2 (Lewis et al., 1988), the proteins belonging 
to the MAP4 family (Aizawa et al., 1990; West et al., 1991; 
Chapin and Bulinski, 1991), tau (Lee et al., 1988), and Dro- 
sophila 205 kD MAP (Irminger-Finger et al.,  1990) have 
acidic  NH2-terminal  and  basic  COOH-terminai  regions; 
MAP2, tan, and MAP4 also have a proline rich region up- 
stream of the basic  microtubule-binding site.  Proline-rich 
regions are predicted to be poorly structured and may cor- 
respond to flexible regions separating functionally different 
domains. 
The  microtubule-binding  site  of E-MAP-115  has  been 
localized to the positively charged NH2-terminal domain. 
It contains the first highly charged region with predicted 
c~-helical structure. Most microtubule-binding sites charac- 
terized so  far are  confined to  positively charged regions 
(e.g., MAP1B [Noble et al., 1989], MAP2/tau [Lewis et al., 
1988],  MAP4  [Aizawa et al.,  1990],  CLIP-170 [Pierre et 
al.,  1992], with the exception of MARPI [Hemphill et al., 
1992]). The microtubule-binding site of E-MAP-115 shows 
no homology to any of the previously characterized sites of 
other microtubule-interactive proteins including the micro- 
tubule-based motor proteins. Interestingly, E-MAP-115 has 
two  highly  charged  predicted  ot-helicai  domains.  These 
oz-helices  show  resemblance  due  to  their  high  contents 
of charged amino acids.  They contain  several clusters of 
charged amino acids reminiscent of the KKE motif which is 
involved in binding of MAP1B (Noble et al.,  1989) and pre- 
sumably MAP1A (Langkopf et al.,  1992) to microtubules. 
Overall, however, the charged amino acids in the predicted 
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tion of E-MAP-115 mutants in 
transfected  Veto cells.  Vero 
cells  were  transfected  with 
cDNA coding for P3 (A and 
B) and Mal  (C and D). Af- 
ter  20  h,  cells  were  either 
directly fixed in methanol (C 
and D), or first treated with 10 
/~m  nocodazole  for  1  h  to 
depolymerize  the  microtu- 
bules (A and B), and double- 
labeled  for E-MAP-115 with 
mAbs against the myc tag (A) 
or D9C1 (C) and tubulin with 
a rabbit polyclonal antiserum 
(B and D).  Myc-tagged mu- 
taut  P3  (first 213  aa)  binds 
to and stabilizes microtubules 
as  efficiently  as  wild-type 
E-MAP-115, whereas mutant 
Mal  (lacking aa 77-228)  re- 
mains cytosolic. Bar, 20/zm. 
a-helices of E-MAP-115  appear to be randomly arranged 
and no clear motif  can be identified. Both predicted a-helical 
domains begin with homologous stretches of 18 amino acids. 
Although identical in size to the MAP2/tau repeats which 
are involved in microtubule-binding (Lewis et al., 1988; Lee 
et al., 1988), we could not detect significant similarities be- 
tween these sequences. The basic NH2 terminus, including 
the predicted a-helix, contains the microtubule-binding site, 
while the second is nearly neutral and appears not to interact 
with  microtubnles.  The physiological role of this  second 
charged region is unclear at the moment. It may be specu- 
lated,  however, that these two domains may interact with 
each other upon posttranslational modifications; such an in- 
teraction might regulate the microtubule-binding and stabil- 
ization properties of E-MAP-115.  In fact these two a-helical 
domains are connected via a  putative hinge in the PAPA- 
region. 
Transient overexpression of E-MAP-115 (and its microtu- 
bule-binding site) in Vero cells, which lack significant levels 
of this protein, leads to stabilization of microtubules and the 
formation of noncentrosomal microtubules. In addition, its 
localization and expression in tissue culture cells correlates 
with the presence of stable microtubules. In all cells ana- 
lyzed,  E-MAP-115  is  most abundant  on microtubule seg- 
ments proximal to the MTOC. These domains are more sta- 
ble than the peripheral plus ends,  which show alternating 
phases  of growth  or  rapid  shrinkage  (Soltys  and  Borisy, 
1985). Expression of E-MAP-115 is significantly increased 
in epithelial cells, where it has been shown that microtubules 
become stabilized (in contrast to fibroblasts) upon establish- 
ment of cell-ceil junctions and polarization (Pepperkok et 
al., 1990; Wadsworth and McGrail, 1990; Br6 et al., 1990). 
This stabilization could occur by the formation of stable seg- 
ments  which  subsequently  serve  as  seeds  for  growth  of 
longer (non-centrosomai) microtubules.  E-MAP-115 could 
indeed be directly involved in the stabilization and reorgani- 
zation of microtubules. 
Several mechanisms may lead to the (local) stabilization 
of interphase  microtubules;  their  dynamic  ends  may  be 
"capped" by interaction with other cytoplasmic structures 
(e.g.,  the  MTOC  or  domains  at  the  plasma  membrane; 
Kirschner and Mitchison, 1986; Mogensen et al., 1989), and 
MAPs may laterally associate with the tubulin polymer. It 
is unlikely that subclasses of microtubules with different sta- 
bilities arise from polymerization of different tubulin iso- 
types (Lewis et al.,  1987;  Lopata and Cleveland, 1987;  for 
review see Murphy, 1991). Posttranslational modifications of 
tubulin correlate with microtubule stability but are rather the 
result than the cause of stability (Webster et al.,  1990; Br6 
et al.,  1987).  This is consistent with our observation that 
microtubules with detyrosinated tubulin are usually positive 
for E-MAP-115,  but not vice versa, indicating that E-MAP- 
115 associates with microtubules before modification of the 
tubulin  subunits.  Transient  interactions  with  cytoplasmic 
membrane domains, for example, may initially render sub- 
sets of microtubules more stable and thus favor association 
of MAPs.  Subsequent stabilization by MAPs will be most 
specific if these proteins are present at subsaturating levels. 
Several lines of evidence suggest that E-MAP-115 is indeed 
nonsaturating with respect to polymerized tubulin in HeLa 
cells and fibroblasts.  On the one hand,  E-MAP-115 is as- 
sociated with subdomains of microtubules, and labeling is 
not  continuous along  a  single microtubule.  On  the other 
hand, E-MAP-115 labels microtubules uniformly when they 
are reduced in number (by drug treatment). Furthermore, 
since no E-MAP-115 can be detected by immunoblotting in 
the  supernatant  after  sedimentation  of taxol-polymerized 
HeLa microtubules, it is unlikely that a significant pool of 
soluble E-MAP-115 exists.  Finally, E-MAP-115 appears to 
have high affinity for polymerized tubulin.  Exchange and 
redistribution of the MAP to newly polymerized, dynamic 
microtubules will thus be slow, giving rise to the establish- 
ment of subdomains or subsets of microtubules. A higher ra- 
tio of  the microtubule-stabilizing MAPs to tubulin should re- 
sult in an increased number of stabilized (non-centrosomal) 
microtubules. Whether higher expression of E-MAP-115 in 
epithelial cells is the trigger for microtubule stabilization or 
a consequence of cellular polarization remains to be inves- 
tigated. 
The physiological role of a putative stabilization of micro- 
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stabilized microtubules have been implicated in the move- 
ment of intracellular organelles (Matteoni and Kreis,  1987; 
Ho et al., 1988; Miller et al., 1987). Interestingly,  E-MAP- 
115 is associated with only few microtubules in fibroblasts. 
Whether  organelle  movement  occurs  preferentially  along 
these microtubules  remains  to be  shown.  Stabilization of 
microtubules by E-MAP-115  may also lead to rearrangement 
of microtubules in polarizing epithelial cells, from a prefer- 
entially centrosome-nucleated pattern in sparse cultures to 
a predominantly  noncentrosome-nucleated  organization in 
polarized cells (Br6 et al., 1990). More experiments, includ- 
ing analysis of the distribution  of E-MAP-115  in tissues and 
during  development,  will be  necessary  to understand  the 
precise role of E-MAP-115  in the organization of the cyto- 
plasm.  Our data  so far suggest that E-MAP-115  is a novel 
microtubule-associated  protein,  whose expression may be 
involved in regulating  microtubule stability. 
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